Urinary Retention Due To Benign Enlarged Prostate Treated Differently In 15 Countries
Men who experience a sudden inability to pass urine because of a non-cancerous enlarged prostate are hospitalised and treated differently depending on where they live, according to an international study published online by the urology journal BJUI. The paper, which will appear in the January issue, reports on how nearly 1, 000 clinicians in 15 countries responded to this urological emergency in more than 6, 000 men. "Acute urinary retention (AUR) is a severe complication of benign prostatic hyperplasia (BPH) characterised by a sudden and painful inability to urinate" explains lead author Professor John Fitzpatrick from Mater Misericordiae University Hospital and University College, Dublin, Ireland.
First Ever All-Ireland Cancer Atlas Shows Cancer Risk In Northern Ireland Lower Than The Republic Of Ireland
People in Northern Ireland have a lower risk of developing some cancers than those living in the Republic of Ireland, according to the All-Ireland Cancer Atlas - a collaborative publication by the Northern Ireland Cancer Registry at Queen's University Belfast and the National Cancer Registry in Cork. The first ever All-Ireland Cancer Atlas analysed 18 types of cancer by electoral division over a 12-year period. Those cancers which were significantly higher for both sexes in the Republic of Ireland were: Non-melanoma skin cancer Melanoma Leukaemia Bladder Pancreas Brain/central nervous system cancers For men, the risk of prostate cancer was higher in the Republic of Ireland and, for women, cancer of the oesophagus and cervix were higher.
Side Effects Of Breast Cancer Drugs Can Be So Bad Women End Treatment And Risk Return Of Cancer
Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves -- as well as the largest, most scientifically rigorous study to examine the question -- reports 36 percent of women quit early because of the medications' side effects, which are more severe and widespread than previously known. The Northwestern Medicine research also reveals a big gap between what women tell their doctors about side effects and what they actually experience.